Wheeler, Sarah E
Mayo Clinic
Associate Professor of Pathology, University of Pittsburgh School of Medicine; Medical Director of UPMC Mercy and UPMC Children's Hospital Automated Testing Laboratories, Associate Director of UPMC Presbyterian Clinical Immunopathology Laboratory, Pittsbur
Citations 2
Clinical Laboratory Informatics and Analytics: Challenges and Opportunities
Wheeler, Sarah , Block, Darci R , Bunch, Dustin R. , Gramz, Jamie, Leung, Edward Ki Yun , McClintock, David S. , Tuthill, J. Mark, Wheeler, Sarah E , Gramz, Jamie
Clinical Chemistry | October 20, 2022 | Volume: 68 | Issue: 11 | Pages: 1361-1367
The Role of Antibody Testing for SARS-CoV-2: Is There One?
Theel, Elitza S. , Slev, Patricia, Wheeler, Sarah , Couturier, Marc Roger , Wong, Susan J. , Kadkhoda, Kamran , Wheeler, Sarah E
Journal of Clinical Microbiology | April 29, 2020 | Volume: 58 | Issue: 8 | Pages: No page available
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brought with it rapid development of both molecular and serologic assays for identification of COVID-19 infections. While Food and Drug Administration (FDA) emergency use authorization (EUA) is required for clinical application of SARS-CoV-2 molecular tests, submission for EUA is currently a voluntary process for manufacturers of serologic assays. The absence of FDA oversight of serologic tests is concerning given that the commercially available serologic assays are highly variable, differing in their format, the antibody class detected, the targeted antigen, and the acceptable specimen types.